I agree there is no compromise, but found it interesting what he wrote. Is he a know it all, perhaps, but more importantly is the company he works for approved by the FDA and are they having problems? Yes and no:
I do appreciate his input, whether I like it or not. I'm happy his company is private so it doesn't affect our share price. If Kristin Comella compromises with the FDA then USRM, Patients, and Investors all have a lot to gain from it. Kristin Comella realizes that and she is just in a bargaining stage with the FDA. However in the meantime are competitors who have approval are going to grow soon and faster. So if they have comments whether useful or annoying, let's learn from it what we can and start growing too.
If you are a potential patient wouldn't you want to choose a facility with an FDA approval over one who isn't. However as an investor wouldn't you want to invest in a company who will soon be FDA approved, rather than that one which already is. Of course, once a compromise is made, kaboom we go way up. Go USRM $$$$$
News 
Market Data 
Discover 
